Conference: Tuesday 18th April 2023
Evening Networking Reception: Tuesday 18th April 2023
Leonardo Royal Hotel London St Paul’s
Collaborate to Innovate is the driving theme of the Pistoia Alliance Annual Spring Conference taking place at the Leonardo Royal Hotel London St Paul’s. Through a mixture of plenary presentations, panel discussions, breakout groups, poster presentations and networking activities, the conference will examine the challenges and opportunities for precompetitive collaboration across the biopharma value chain. The conference will also review the status of current and proposed Pistoia Alliance projects that aim to lower barriers to innovation in life science R&D.
Registration is now closed
Speakers Include:
Becky Upton, President, Pistoia Alliance
Julie Huxley-Jones, VP Scientific Digital & Tech at GSK
Gabriel Boronat, Director, Regulatory Information Management, Janssen
Kailash Swarna, Managing Director & Global Leader, Clinical Development, Accenture Life Sciences
Sheila Elz, Master Data Manager, Bayer AG
Elliot Ford, NLP Engineer, AstraZeneca
Joe Mullen, Director of Technical Consultants, SciBite
Richard Jackson, NLP Engineer, AstraZeneca
Valentina Eigner-Pitto, Principal Solutions Consultant, CAS Custom Services
Maren Monnich, Product Owner, Discovery & Tools, GSK
Martin Erkens, Head Pharma Research and Early Development Informatics (pRED Informatics), Roche
Christian Baber, Head of Scientific & Pharmaceutical Data, Informatics & Systems, Janssen
John Reinhard Pietzsch, Head of Data Science & Insights, Bayer
Margaux Soules, Life Sciences Senior Solution Consultant, BIOVIA
Paul O’Donohoe, Senior Director, eCOA Product and Science, Medidata Solutions
Pablo Porras Millán, Data Curation Director,
Ian Smith, Chief Technology Officer, Optibrium
Carly Santer, Impact Officer, Bayer UK/Ireland
James Man, Managing Director R&D Advisory, Syneos Health
Heiner Oberkampf, CEO, ACCURIDS
Marc Siladi, VP of Science & Technology, Strateos
Anthony Rowe, Head of Technology – Global Scientific IT, Janssen
Anca Ciobanu, Consultant, Pistoia Alliance
Bertram Weiss, Head of Digital Transformation and IT, Bayer
Nicola Oxby, Global Director, GSK
Efi Hoffmann, co-CPO, Chemaxon
Sponsors
If you would like further information on the sponsorship opportunities available at the event, please contact zahid.tharia@pistoiaalliance.org.
Tuesday 18th April 2023
| 08.00 | Registration | ||
| 09.05 | President’s introduction | Becky Upton, President, Pistoia Alliance | |
| 09.20 | Keynote Presentation: Product data management aboard the ship of Theseus
|
Gabriel Boronat, Director, Regulatory Information Management, Janssen
|
|
| 09.50 | Introduction to breakout groups | Hall Gregg, Chief Portfolio Officer, Pistoia Alliance | |
| 10:00 | Keynote Address: A connected data ecosystem for accelerated insights: data42 and beyond
|
Achim Plueckebaum, SVP Data42, Novartis | |
| 10:30 | Leveraging Real World Data, ‘Omics Data, and AI for R&D
|
Kailash Swarna, Managing Director & Global Leader, Clinical Development, Accenture Life Sciences
Sheila Elz, Master Data Manager, Bayer AG |
|
| 11.20 | Morning Break |
|
|
| 11.50 | Partners in R&D Innovation | Leveraging advanced knowledge management to uncover hidden value in R&D proprietary information
Valentina Eigner-Pitto, Principal Solutions Consultant, CAS Custom Services Margaux Soules, Life Sciences Senior Solution Consultant, BIOVIA Enabling R&D using Data Centric Approaches |
|
| 12.35 | Lunch |
|
|
|
|
Breakout One
Chair: Anthony Rowe, Head of Technology – Global Scientific IT, Janssen 13.35 Opening Remarks Data Strategy in R&D and post marketing 13.40 AI in Pharmacovigilance John Reinhard Pietzsch, Head of Data Science & Insights, Bayer 13.55 Building the ARC: GSK is producing more data than ever before. We have new AI/ML use cases, a modern landscape with a myriad of disparate data sources and more complex data restriction rules. Our legacy systems are not built to handle the volume, variety or density of data coming from our assays today. To address this we are developing ARC – a cloud based assay data repository built to flexibly handle petabytes of data with simplified governance and ALCOA+ compliance. Maren Monnich, Product Owner, Discovery & Tools, GSK 14.10 NLP Use Case: Enterprise biomedical NER and linking with Kazu Elliot Ford, NLP Engineer, AstraZeneca Richard Jackson, NLP Engineer, AstraZeneca
14.30 FAIR Benchmarking Pablo Porras Millán, Data Curation Director, AstraZeneca 14.45 AI-driven drug discovery: Bringing together modern architecture, infrastructure and data strategies for success
Ian Smith, Chief Technology Officer, Optibrium 15:00 Discussion 15.15 Close
|
Breakout Two
Chair: Thierry Escudier, Consultant, Pistoia Alliance 13.35 Opening Remarks Reducing the Carbon Footprint of Clinical Trials 13.40 : Towards greener healthcare: The power of partnership Keith Moore, Sustainable Healthcare Coalition 13.55 : Joining the dots and trade offs for sustainability in Bayer pharma R&D Carly Santer, Impact Officer, Bayer UK/Ireland 14.10 : ESG trends hitting biopharmaceutical R&D James Man Managing Director R&D Advisory, Syneos Health 14.25 Planet Health is Human Health: how decentralized trials can make clinical research more patient and earth friendly Michael Cohen, Senior Director Strategy & Innovation, PPD 14.40 The Sustainable Clinical Trial Future Paul O’Donohoe, Senior Director, eCOA Product and Science, Medidata Solutions 14:55 Panel Session: The Pistoia Alliance Project – Carbon Footprint of Clinical Trials 15.15 Close |
Breakout Three Chair: Gerhard Noelken, Project Manager, Pistoia Alliance IDMP Ontology Project 13.35 Opening Remarks 13:40 IDMP Ontology – Overview of Phase 2 Sheila Elz, Master Data Manager, Bayer AG Rafail Kasapis, Data Strategy and Governance Consultant, Osthus 14:00 What IDMP can do for you today? Demo of key use cases Heiner Oberkampf, CEO , ACCURIDS 14.40 Vitality TechNet Presentation 15.15 Close |
| 15:15 | Coffee | ||
| 15.45 | Diversity & Inclusivity Panel | Anca Ciobanu, Consultant, Pistoia Alliance
Bertram Weiss, Head of Digital Transformation and IT, Bayer Nicola Oxby, Global Director, GSK Efi Hoffmann, co-CPO, Chemaxon Sergio Rotstein, VP R&D Solutions, Pfizer |
|
| 16.30 | Partners in R&D Innovation | New from CDD: Bioassay Protocol Registration and PharmaKB a Pharmaceutical KnowledgeBase
Scott Hutton, VP Collaborations, Collaborative Drug Discovery |
|
| 16.45 | Panel Discussion: Shaping the Future of AI in R&D – Opportunities for Precompetitive Collaboration
With pioneering techniques contributing towards ultra-large datasets, and the increased availability of high-performance compute environments, new technologies are being used to power novel discoveries and provide smarter therapeutics. We aim to explore new ways in which AI can improve the drug discovery and development process, examining limitations in its application, highlighting ethical considerations, and discussing the potential for collaboration within the industry to tackle some of our most critical challenges. |
Kailash Swarna, Managing Director & Global Leader, Clinical Development, Accenture Life Sciences Christian Baber, Head of Scientific & Pharmaceutical Data, Informatics & Systems, Janssen Martin Erkens, Head Pharma Research and Early Development Informatics (pRED Informatics), Roche |
|
| 17.30 | Closing Remarks | ||
| 17.45 | Drinks Reception |
|
|
Cancellation policy
Cancellation policy and registrant no shows
- Members can cancel their registration with no penalty up until 17.30 Eastern Standard Time, Tuesday 4th April 2023.
- NOTE: Although there is no fee to attend this event, Members who cancel their registration after this date will be subject to a cancellation fee of $200.
- NOTE: Members who register but fail to inform us of their non-attendance and do not attend will be subject to a cancellation fee of $200.
- The contact address for cancellations is: events@pistoiaalliance.org